All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Abclon Inc. has filled the missing link in its development of antibody-drug conjugates (ADCs) by partnering with Abtis Co. Ltd. and gaining access to its ADC linker.
